Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OncoSil Medical Ltd ( (AU:OSL) ) has issued an announcement.
OncoSil Medical Ltd has lodged a notice of change of interests of a substantial holder under Australia’s Corporations Act, indicating an update to a major shareholder’s voting power in the company. The filing, signed by Chief Operating Officer Keith McLachlan and effective 19 March 2026, reflects altered relevant interests and associations among substantial holders, signalling a shift in the company’s ownership structure that may influence future governance dynamics and investor positioning.
The most recent analyst rating on (AU:OSL) stock is a Hold with a A$0.54 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical Ltd is an Australia-based medical technology company listed on the ASX under the ticker OSL. The company focuses on developing and commercialising oncological medical devices and therapies, targeting cancer treatment markets where innovative radiation and implantable solutions can improve patient outcomes.
Average Trading Volume: 64,838
Technical Sentiment Signal: Sell
Current Market Cap: A$16.88M
See more data about OSL stock on TipRanks’ Stock Analysis page.